Blog
https://womenentrepreneurindia.com/digital-magazine/women-in-pharma-and-lifesciences-may-2022/#page=32 #womeninpharma #ipservices #patentservices
#honor #recognition #gratitude #ipessentia
Thanks, Garima & Sneha for discussing TICAGRELOR, DAPAGLIFLOZIN, CHLORANTRANILIPROLE and SAROGLITAZAR cases at length & sharing the shifting trend. #Genusspeciespatent #disclosurecoverage #interiminjunction #jurisprudence
Thanks, Bird & Bird, Life Sciences team…….. Mark Hilton & Jane Owen, for sharing the recent shift in Interim injunctions in UK & Australia Aden Chen, for providing insights on the implementation of Patent Linkage in China #Patentlinkagechina #interiminjunction #Germanlawupdate #patenttermextension
Thanks, Dr. Roshan & Steve. For providing insights & practice tips based on the key Recent Cases and Trends in the U.S. Litigation. #taft #ReversePaymentSettlement #ChemoursDaikan #GSKTeva #AmarinHikma #ValeantMylan #UCBActavis #ImpaxFTC
https://www.siliconindia.com/digital-magazine/patent-and-trademark-law-services-july-2021/#page=23
Poonam Raghuvanshi Founder Analysing and strategizing Intellectual property has become relatively simpler today, with the help of Patent and Trademark service providers in the market. ipEssentia is a boutique Intellectual Property firm with freshly brewed enthusiasm, empowered by decades of experience in building & leading the in-house Intellectual Property functions of multinational companies. The company […]
The U.S. Supreme Court denied taking up Sandoz’s petition for it to review earlier decisions that had favoured Amgen in the long-running patent litigation. Biosimilar Etanercept is now barred until 2029 in the US. In 2019, New Jersey federal district court ruled in favor of the Amgen, though Sandoz appealed, the U.S. Court of Appeals […]
Once again in Bayer Healthcare LLC v. Baxalta Inc. (Fed. Cir. 2021), the jury awarded Bayer reasonable royalty damages, based on a certain (17.78%) royalty rate for Defendants’ profits. The jury selected a rate between the range presented by the damages expert. The damages expert used a “reliable methodology for determining the range of possible […]
We were recently looking at the European patent landscape of a product for Relapsing-remitting multiple sclerosis (RRMS). There are several divisional patents & patent applications which are part of the core composition patent family and are at various stages of prosecution or opposition (some are revoked & under appeal). While the parent patent was revoked, […]